Abstract:Objectives: Hypoxia is a common pathological phenomenon, usually caused by insufficient oxygen supply or inability to use oxygen effectively. Hydroxylated and methoxylated flavonoids have significant anti-hypoxia activity. This study aims to explore the synthesis, antioxidant and anti-hypoxia activities of 6-hydroxygenistein (6-OHG) and its methoxylated derivatives. Methods: The 6-OHG and its methoxylated derivatives, including 4',6,7-trimethoxy-5-hydroxyisoflavone (compound 3), 4',5,6,7-tetramethoxyisoflavone (compound 4), 4',6-imethoxy-5,7-dihydroxyisoflavone (compound 6), and 4'-methoxy-5,6,7-trihydroxyisoflavone (compound 7), were synthesized by methylation, bromination, methoxylation, and demethylation using biochanin A as raw material. The structure of these products were characterized by 1hydrogen-nuclear magnetic resonance spectroscopy (1H-NMR) and mass spectrometry (MS). The purity of these compounds was detected by high pressure chromatography (HPLC). The antioxidant activity in vitro was investigated by 1,1-diphenyl-2-picrylhydrazyl radical (DPPH) free radical scavenging assay. PC12 cells were divided into a normal group, a hypoxia model group, rutin (1×10-9-1×10-5 mol/L) groups, and target compounds (1×10-9-1×10-5 mol/L) groups under normal and hypoxic conditions. Cell viability was detected by cell counting kit-8 (CCK-8) assay, the target compounds with excellent anti-hypoxia activity and the drug concentration at the maximum anti-hypoxia activity were screened. PC12 cells were treated with the optimal concentration of the target compound or rutin with excellent anti-hypoxia activity, and the cell morphology was observed under light microscope. The apoptotic rate was determined by flow cytometry, and the expressions of hypoxia inducible factor-1α (HIF-1α) and vascular endothelial growth factor (VEGF) were detected by Western blotting. Results: The structure of 6-OHG and its 4 methylated derivatives were correct, and the purity was all more than 97%. When the concentration was 4 mmol/L, the DPPH free radical removal rates of chemical compounds 7 and 6-OHG were 81.16% and 86.94%, respectively, which were higher than those of rutin, the positive control. The removal rates of chemical compounds 3, 4, and 6 were all lower than 20%. Compared with the normal group, the cell viability of the hypoxia model group was significantly decreased (P<0.01). Compared with the hypoxia model group, compounds 3, 4, and 6 had no significant effect on cell viability under hypoxic conditions. At all experimental concentrations, the cell viability of the 6-OHG group was significantly higher than that of the hypoxia model group (all P<0.05). The cell viability of compound 7 group at 1×10-7 and 1×10-6 mol/L was significantly higher than that of the hypoxia model group (both P<0.05). The anti-hypoxia activity of 6-OHG and compound 7 was excellent, and the optimal drug concentration was 1×10-6 and 1×10-7 mol/L. After PC12 cells was treated with 6-OHG (1×10-6 mol/L) and compound 7 (1×10-7 mol/L), the cell damage was reduced, the apoptotic rate was significantly decreased (P<0.01), and the protein expression levels of HIF-1α and VEGF were significantly decreased in comparison with the hypoxia model group (both P<0.01). Conclusions: The optimized synthesis route can increase the yield of 6-OHG and obtain 4 derivatives by methylation and selective demethylation. 6-OHG and compound 7 have excellent antioxidant and anti-hypoxia activities, which are related to the structure of the A-ring ortho-triphenol hydroxyl group in the molecule.

Synthesis, Antioxidant, and Antihypoxia Activities of 6,7,8,4-Tetrahydroxyisoflavone and 6,7,8,3,4-Pentahydroxyisoflavone

The Design, Synthesis, Antioxidant, and Antihypoxia Activities of Two New Hydroxydaidzein Derivatives

A New Synthetic Approach To Isoflavones

Convenient Synthesis, Antioxidant and Anti-Hypoxia Activities of 8-Hydroxy, 3′-Hydroxy, and 8,3′-Dihydroxydaidzein from Daidzein

Anti-inflammatory and Anti-Oxidative Activities of Daidzein and Its Sulfonic Acid Ester Derivatives

Synthesis, antioxidant and anti - hypoxia activities of 6 - hydroxygenistein and its methylated derivatives

Anti-hemolysis of Human Erythrocytes by Two Daidzein Derivatives Containing Nitrogen

Synthesis and antioxidant activities of two new water soluble lsoflavone derivatives

Synthesis and Anti-Hypoxia Activity of Water Soluble Derivatives of 5-Methyl-7, 4'-Dihydroxyisoflavone

Synthesis and Antioxidant Activities of 5,7,4'-Tri (hydroxyl) Isoflavonyl-8-azophenylsulfonic Acid

Total Synthesis of 2-Methyl-7-[omega-(1H-imidazol-1-yl)ethoxy] - Isoflavone Derivatives and Their Antioxidative Activity

Synthesis, Crystal Structure and Activity of Sulfated Daidzein

Synthesis and Antioxidative Activity of 2-Methyl-benzoimidazolyl Isoflavone Derivatives

Daidzein As an Antioxidant of Lipid: Effects of the Microenvironment in Relation to Chemical Structure.

Synthesis and determination of antioxidative activity of 2-methyl-7-(2-(1H-(2-methyl-benzoimidazole)-1-yl) ethoxy)-4'-methoxy isoflavone

Synthesis and Antioxidation Properties of Two 4 '-P-toluenesulfonyloxyisoflavone Derivatives

Synthesis and Cytotoxicity Evaluation of 3-Amino-2-hydroxypropoxygenistein Derivatives.

Synthesis and Cytotoxicity Evaluation of 3-Amino-2-hydroxypropoxyisoflavone Derivatives.

Syntheses, crystal structures and biological activity of bimethylation daidzein sulfonates

Design of acid-responsive polymeric nanoparticles for 7,3',4'-trihydroxyisoflavone topical administration

7,8‐dihydroxyflavone displayed antioxidant effect through activating HO‐1 expression and inhibiting caspase‐3/PARP activation in RAW264.7 cells